Takeda-Protagonist Therapeutics Partnered Investigational Drug Hits Primary Goal In Late-Stage Study In Patients With Type Of Blood Cancer
Protagonist Therapeutics, Inc · PHARMACEUTICAL PREPARATIONS · Now $94.92
+2.6% in 1d after detection
Post-detection moves
1h
—
1d
+2.6%
3d
+0.8%
7d
+1.2%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS